Cardiac rhythm abnormalities during intravenous immunoglobulin G infusion for treatment of thrombocytopenia

Journal of Pediatric Hematology/Oncology

Volumn 19, Issue 3, 1997, Pages 254-257

  Savaşan, Süreyya ^a,b   Tuzcu, Volkan ^a   Warrier, Indira ^a   Karpawich, Peter ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

Author keywords

Cardiac rhythm abnormalities; Intravenous immunoglobulin G

Indexed keywords

IMMUNOGLOBULIN G; PHENYTOIN; PROPRANOLOL; VERAPAMIL;

ARTICLE; CASE REPORT; CHILD; HEART ARRHYTHMIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LONG QT SYNDROME; MALE; PRIORITY JOURNAL; SUPRAVENTRICULAR TACHYCARDIA; THROMBOCYTOPENIA;

ARRHYTHMIA; CHILD; ELECTROCARDIOGRAPHY; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; THROMBOCYTOPENIA;

EID: 0343923734     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199705000-00015     Document Type: Article

References (16)

1. Imbach P, Akatsuka J, Blanchette V, et al. Immunthrombocytopenic purpura as a model for pathogenesis and treatment of autoimmunity. Eur J Pediatr 1995;154 (Suppl 3):S60-4.
2. Foley-Nolan D, Gooi HC. Current rheumatological uses of intravenous immunoglobulin. Br J Rheumatol 1994;33:1002-6.
3. Duhem C, Dicato MA, Ries F. Side-effects of intravenous immune globulins. Clin Exp Immunol 1994;97(Suppl 1):79-83.
4. Bjoro K, Froland SS, Yun Z, et al. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N Engl J Med 1994;331:1607-11.
5. Burks AW, Sampson HA, Buckley RH. Anaphylactic reactions after gammaglobulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA. N Engl J Med 1986;314:560-3.
6. Tan E, Hajinazarian M, Bay W, et al. Acute renal failure resulting from intravenous immunoglobulin therapy. Arch Neurol 1993;50:137-9.
7. Woodruf RK, Grigg AP, Firkin FC, et al. Fatal thrombotic events during treatment of autoimmune thrombocytopenia with intravenous immunoglobulin in elderly patients. Lancet 1986;II:217-8.
8. Dalakas MC. High dose intravenous immunoglobulin and serum viscosity: Risk of precipitating thromboembolic events. Neurology 1994;44:223-6.
9. Sekul EA, Cupler EJ, Dalakas MC. Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: Frequency and risk factors. Ann Intern Med 1994;121:259-62.
10. Blanchette VS, Luke B, Andrew M, et al. A prospective randomized trial of high dose intravenous immunoglobulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. J Pediatr 1993;123:989-95.
11. Thomas MJ, Misbah SA, Chapel HM, et al. Hemolysis after high dose intravenous immunoglobulin. Blood 1993;82:3789.
12. Buyon JP. Neonatal lupus syndromes. Curr Opin Rheumatol 1994;6:523-9.
13. Reichlin M, Brucato A, Frank MB, et al. Concentration of autoantibodies to native 60 kD Ro/SS-A and denatured 52 kD Ro/SS-A in elutes from the heart of a child who died with congenital complete heart block. Arthritis Rheum 1994;37:1698-703.
14. Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: Cellular receptor for B19 parvovirus. Science 1993;262:114-7.
15. Morey AL, Keeling JW, Porter HJ, et al. Clinical and histopathological features of parvovirus B19 infection on the human fetus. Br J Obstet Gynaecol 1992;99:566-74.
16. Freedman RA, Anderson KP, Green LS, et al. Effect of erythromycin on ventricular arrhythmias and ventricular repolarization in idiopathic long QT syndrome. Am J Cardiol 1987;59:168-9.